Skip to content

Mesoblast

US · MESO #2849 by market cap Listed 2015
10.89 -0.29 -2.59%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 5 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.5 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
28.80% -0.49pp
Institutions
110 -5
As of
2026/Q3 vs. prior period

Holder types

Individual/Insider34.17%
Mutual Fund17.73%
Public Company6.44%
Private Company1.70%
VC/PE Fund1.08%
Government Pension Fund0.88%
Sovereign Wealth Fund0.85%
Other37.02%

Top holders as of 2026-09-18

Gregory George 20.95% · 27.20M sh
Silviu Itescu 6.23% · 8.08M sh
State Street Global Advisors 5.16% · 6.70M sh
William Gueck 4.80% · 6.24M sh
JPMorgan Chase & Co. 4.65% · 6.04M sh
M&G Investment Management Limited 2.73% · 3.55M sh
Vanguard Capital Management, LLC 2.47% · 3.21M sh
BlackRock 1.87% · 2.43M sh
Vanguard Investments Australia Limited 1.57% · 2.04M sh
Dimensional Fund Advisors 1.36% · 1.76M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

25 filings tracked · 1 buys · 0 sells

NameRoleStake
Gregory George Non-Independent Non-Executive Director 20.95%
Silviu Itescu Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director 6.23%
Eric Rose Chief Medical Officer 0.52%
Jane Bell Independent Non-Executive Director 0.05%
Philip Krause Former Non-Independent Non Executive Director 0.02%
William Burns Former Independent Non-Executive Vice Chairman 0.02%
Lynette Cobley Independent Non-Executive Director 0.00%
Philip Facchina Independent Non-Executive Chair of the Board 0.00%
Josaka Investments Pty Ltd. -- --
James O’Brien Chief Financial Officer --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-03-17 Eric Rose Chief Medical Officer Initial Statement of Beneficial 0 --
2026-03-17 Philip Facchina Independent Non-Executive Chair of the Board Initial Statement of Beneficial 0 --
2026-03-17 William Burns Former Independent Non-Executive Vice Chairman Initial Statement of Beneficial 0 --
2026-03-17 Silviu Itescu Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director Initial Statement of Beneficial 0 --
2026-03-17 Lynette Cobley Independent Non-Executive Director Initial Statement of Beneficial 0 --
2026-03-17 Josaka Investments Pty Ltd. -- Initial Statement of Beneficial 0 --
2026-03-17 Jane Bell Independent Non-Executive Director Initial Statement of Beneficial 0 --
2026-03-17 Philip Krause Former Non-Independent Non Executive Director Initial Statement of Beneficial 0 --
2026-03-17 Gregory George Non-Independent Non-Executive Director Initial Statement of Beneficial 0 --
2026-03-15 Gregory George Non-Independent Non-Executive Director Initial Statement of Beneficial 0 --
2025-12-22 James O’Brien Chief Financial Officer Other Derivative Acquisition +650,000 $2.90

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Mesoblast discussion 0 comments

Add a comment